Global Contraceptives Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 110
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Contraceptives Drugs market size was valued at USD 12810 million in 2023 and is forecast to a readjusted size of USD 19790 million by 2030 with a CAGR of 6.4% during review period.
Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation.
The contraceptives market is driven by the increasing awareness and adoption of family planning methods to control population growth and improve maternal and child health. Contraceptives provide individuals with choices for safe and effective birth control, leading to a decline in unintended pregnancies and a healthier reproductive population. Moreover, government initiatives and awareness campaigns aimed at promoting family planning further contribute to market growth. However, challenges include cultural and social barriers, lack of access to contraceptives in certain regions, and potential side effects associated with some contraceptive methods. Addressing these challenges through education, improved access to contraceptives, and the development of innovative and user-friendly contraceptive options will be crucial for sustaining the growth of the contraceptives market.
The Global Info Research report includes an overview of the development of the Contraceptives Drugs industry chain, the market status of Hospital (Long-acting Contraceptives, Short-acting Contraceptives), Pharmacy (Long-acting Contraceptives, Short-acting Contraceptives), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Contraceptives Drugs.
Regionally, the report analyzes the Contraceptives Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Contraceptives Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Contraceptives Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Contraceptives Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Unit), revenue generated, and market share of different by Type (e.g., Long-acting Contraceptives, Short-acting Contraceptives).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Contraceptives Drugs market.
Regional Analysis: The report involves examining the Contraceptives Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Contraceptives Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Contraceptives Drugs:
Company Analysis: Report covers individual Contraceptives Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Contraceptives Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Contraceptives Drugs. It assesses the current state, advancements, and potential future developments in Contraceptives Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Contraceptives Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Contraceptives Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives
Market segment by Application
Hospital
Pharmacy
Other
Major players covered
Bayer
Pfizer
Teva Pharmaceutical
Merck
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Contraceptives Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Contraceptives Drugs, with price, sales, revenue and global market share of Contraceptives Drugs from 2019 to 2024.
Chapter 3, the Contraceptives Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Contraceptives Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Contraceptives Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Contraceptives Drugs.
Chapter 14 and 15, to describe Contraceptives Drugs sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Contraceptives Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Contraceptives Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Long-acting Contraceptives
1.3.3 Short-acting Contraceptives
1.3.4 Emergency Contraceptives
1.4 Market Analysis by Application
1.4.1 Overview: Global Contraceptives Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Other
1.5 Global Contraceptives Drugs Market Size & Forecast
1.5.1 Global Contraceptives Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Contraceptives Drugs Sales Quantity (2019-2030)
1.5.3 Global Contraceptives Drugs Average Price (2019-2030)
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Contraceptives Drugs Product and Services
2.1.4 Bayer Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bayer Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Contraceptives Drugs Product and Services
2.2.4 Pfizer Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments/Updates
2.3 Teva Pharmaceutical
2.3.1 Teva Pharmaceutical Details
2.3.2 Teva Pharmaceutical Major Business
2.3.3 Teva Pharmaceutical Contraceptives Drugs Product and Services
2.3.4 Teva Pharmaceutical Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Teva Pharmaceutical Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Contraceptives Drugs Product and Services
2.4.4 Merck Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck Recent Developments/Updates
2.5 Actavis
2.5.1 Actavis Details
2.5.2 Actavis Major Business
2.5.3 Actavis Contraceptives Drugs Product and Services
2.5.4 Actavis Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Actavis Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Contraceptives Drugs Product and Services
2.6.4 Johnson & Johnson Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Gedeon Richter
2.7.1 Gedeon Richter Details
2.7.2 Gedeon Richter Major Business
2.7.3 Gedeon Richter Contraceptives Drugs Product and Services
2.7.4 Gedeon Richter Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Gedeon Richter Recent Developments/Updates
2.8 Novo Nordisk A/S
2.8.1 Novo Nordisk A/S Details
2.8.2 Novo Nordisk A/S Major Business
2.8.3 Novo Nordisk A/S Contraceptives Drugs Product and Services
2.8.4 Novo Nordisk A/S Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Novo Nordisk A/S Recent Developments/Updates
2.9 ZiZhu
2.9.1 ZiZhu Details
2.9.2 ZiZhu Major Business
2.9.3 ZiZhu Contraceptives Drugs Product and Services
2.9.4 ZiZhu Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 ZiZhu Recent Developments/Updates
2.10 Baijingyu
2.10.1 Baijingyu Details
2.10.2 Baijingyu Major Business
2.10.3 Baijingyu Contraceptives Drugs Product and Services
2.10.4 Baijingyu Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Baijingyu Recent Developments/Updates
2.11 Huazhong
2.11.1 Huazhong Details
2.11.2 Huazhong Major Business
2.11.3 Huazhong Contraceptives Drugs Product and Services
2.11.4 Huazhong Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Huazhong Recent Developments/Updates
3.1 Global Contraceptives Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Contraceptives Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Contraceptives Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Contraceptives Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Contraceptives Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Contraceptives Drugs Manufacturer Market Share in 2023
3.5 Contraceptives Drugs Market: Overall Company Footprint Analysis
3.5.1 Contraceptives Drugs Market: Region Footprint
3.5.2 Contraceptives Drugs Market: Company Product Type Footprint
3.5.3 Contraceptives Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Contraceptives Drugs Market Size by Region
4.1.1 Global Contraceptives Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Contraceptives Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Contraceptives Drugs Average Price by Region (2019-2030)
4.2 North America Contraceptives Drugs Consumption Value (2019-2030)
4.3 Europe Contraceptives Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Contraceptives Drugs Consumption Value (2019-2030)
4.5 South America Contraceptives Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Contraceptives Drugs Consumption Value (2019-2030)
5.1 Global Contraceptives Drugs Sales Quantity by Type (2019-2030)
5.2 Global Contraceptives Drugs Consumption Value by Type (2019-2030)
5.3 Global Contraceptives Drugs Average Price by Type (2019-2030)
6.1 Global Contraceptives Drugs Sales Quantity by Application (2019-2030)
6.2 Global Contraceptives Drugs Consumption Value by Application (2019-2030)
6.3 Global Contraceptives Drugs Average Price by Application (2019-2030)
7.1 North America Contraceptives Drugs Sales Quantity by Type (2019-2030)
7.2 North America Contraceptives Drugs Sales Quantity by Application (2019-2030)
7.3 North America Contraceptives Drugs Market Size by Country
7.3.1 North America Contraceptives Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Contraceptives Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Contraceptives Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Contraceptives Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Contraceptives Drugs Market Size by Country
8.3.1 Europe Contraceptives Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Contraceptives Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Contraceptives Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Contraceptives Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Contraceptives Drugs Market Size by Region
9.3.1 Asia-Pacific Contraceptives Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Contraceptives Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Contraceptives Drugs Sales Quantity by Type (2019-2030)
10.2 South America Contraceptives Drugs Sales Quantity by Application (2019-2030)
10.3 South America Contraceptives Drugs Market Size by Country
10.3.1 South America Contraceptives Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Contraceptives Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Contraceptives Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Contraceptives Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Contraceptives Drugs Market Size by Country
11.3.1 Middle East & Africa Contraceptives Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Contraceptives Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Contraceptives Drugs Market Drivers
12.2 Contraceptives Drugs Market Restraints
12.3 Contraceptives Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Contraceptives Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Contraceptives Drugs
13.3 Contraceptives Drugs Production Process
13.4 Contraceptives Drugs Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Contraceptives Drugs Typical Distributors
14.3 Contraceptives Drugs Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Contraceptives Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Contraceptives Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Contraceptives Drugs Product and Services
Table 6. Bayer Contraceptives Drugs Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bayer Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Contraceptives Drugs Product and Services
Table 11. Pfizer Contraceptives Drugs Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Pfizer Recent Developments/Updates
Table 13. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceutical Major Business
Table 15. Teva Pharmaceutical Contraceptives Drugs Product and Services
Table 16. Teva Pharmaceutical Contraceptives Drugs Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Teva Pharmaceutical Recent Developments/Updates
Table 18. Merck Basic Information, Manufacturing Base and Competitors
Table 19. Merck Major Business
Table 20. Merck Contraceptives Drugs Product and Services
Table 21. Merck Contraceptives Drugs Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Merck Recent Developments/Updates
Table 23. Actavis Basic Information, Manufacturing Base and Competitors
Table 24. Actavis Major Business
Table 25. Actavis Contraceptives Drugs Product and Services
Table 26. Actavis Contraceptives Drugs Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Actavis Recent Developments/Updates
Table 28. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 29. Johnson & Johnson Major Business
Table 30. Johnson & Johnson Contraceptives Drugs Product and Services
Table 31. Johnson & Johnson Contraceptives Drugs Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Johnson & Johnson Recent Developments/Updates
Table 33. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 34. Gedeon Richter Major Business
Table 35. Gedeon Richter Contraceptives Drugs Product and Services
Table 36. Gedeon Richter Contraceptives Drugs Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Gedeon Richter Recent Developments/Updates
Table 38. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 39. Novo Nordisk A/S Major Business
Table 40. Novo Nordisk A/S Contraceptives Drugs Product and Services
Table 41. Novo Nordisk A/S Contraceptives Drugs Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Novo Nordisk A/S Recent Developments/Updates
Table 43. ZiZhu Basic Information, Manufacturing Base and Competitors
Table 44. ZiZhu Major Business
Table 45. ZiZhu Contraceptives Drugs Product and Services
Table 46. ZiZhu Contraceptives Drugs Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. ZiZhu Recent Developments/Updates
Table 48. Baijingyu Basic Information, Manufacturing Base and Competitors
Table 49. Baijingyu Major Business
Table 50. Baijingyu Contraceptives Drugs Product and Services
Table 51. Baijingyu Contraceptives Drugs Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Baijingyu Recent Developments/Updates
Table 53. Huazhong Basic Information, Manufacturing Base and Competitors
Table 54. Huazhong Major Business
Table 55. Huazhong Contraceptives Drugs Product and Services
Table 56. Huazhong Contraceptives Drugs Sales Quantity (K Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Huazhong Recent Developments/Updates
Table 58. Global Contraceptives Drugs Sales Quantity by Manufacturer (2019-2024) & (K Unit)
Table 59. Global Contraceptives Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Contraceptives Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 61. Market Position of Manufacturers in Contraceptives Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 62. Head Office and Contraceptives Drugs Production Site of Key Manufacturer
Table 63. Contraceptives Drugs Market: Company Product Type Footprint
Table 64. Contraceptives Drugs Market: Company Product Application Footprint
Table 65. Contraceptives Drugs New Market Entrants and Barriers to Market Entry
Table 66. Contraceptives Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Contraceptives Drugs Sales Quantity by Region (2019-2024) & (K Unit)
Table 68. Global Contraceptives Drugs Sales Quantity by Region (2025-2030) & (K Unit)
Table 69. Global Contraceptives Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Global Contraceptives Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 71. Global Contraceptives Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 72. Global Contraceptives Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 73. Global Contraceptives Drugs Sales Quantity by Type (2019-2024) & (K Unit)
Table 74. Global Contraceptives Drugs Sales Quantity by Type (2025-2030) & (K Unit)
Table 75. Global Contraceptives Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Global Contraceptives Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Global Contraceptives Drugs Average Price by Type (2019-2024) & (USD/Unit)
Table 78. Global Contraceptives Drugs Average Price by Type (2025-2030) & (USD/Unit)
Table 79. Global Contraceptives Drugs Sales Quantity by Application (2019-2024) & (K Unit)
Table 80. Global Contraceptives Drugs Sales Quantity by Application (2025-2030) & (K Unit)
Table 81. Global Contraceptives Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Global Contraceptives Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Global Contraceptives Drugs Average Price by Application (2019-2024) & (USD/Unit)
Table 84. Global Contraceptives Drugs Average Price by Application (2025-2030) & (USD/Unit)
Table 85. North America Contraceptives Drugs Sales Quantity by Type (2019-2024) & (K Unit)
Table 86. North America Contraceptives Drugs Sales Quantity by Type (2025-2030) & (K Unit)
Table 87. North America Contraceptives Drugs Sales Quantity by Application (2019-2024) & (K Unit)
Table 88. North America Contraceptives Drugs Sales Quantity by Application (2025-2030) & (K Unit)
Table 89. North America Contraceptives Drugs Sales Quantity by Country (2019-2024) & (K Unit)
Table 90. North America Contraceptives Drugs Sales Quantity by Country (2025-2030) & (K Unit)
Table 91. North America Contraceptives Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 92. North America Contraceptives Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Europe Contraceptives Drugs Sales Quantity by Type (2019-2024) & (K Unit)
Table 94. Europe Contraceptives Drugs Sales Quantity by Type (2025-2030) & (K Unit)
Table 95. Europe Contraceptives Drugs Sales Quantity by Application (2019-2024) & (K Unit)
Table 96. Europe Contraceptives Drugs Sales Quantity by Application (2025-2030) & (K Unit)
Table 97. Europe Contraceptives Drugs Sales Quantity by Country (2019-2024) & (K Unit)
Table 98. Europe Contraceptives Drugs Sales Quantity by Country (2025-2030) & (K Unit)
Table 99. Europe Contraceptives Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Contraceptives Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Contraceptives Drugs Sales Quantity by Type (2019-2024) & (K Unit)
Table 102. Asia-Pacific Contraceptives Drugs Sales Quantity by Type (2025-2030) & (K Unit)
Table 103. Asia-Pacific Contraceptives Drugs Sales Quantity by Application (2019-2024) & (K Unit)
Table 104. Asia-Pacific Contraceptives Drugs Sales Quantity by Application (2025-2030) & (K Unit)
Table 105. Asia-Pacific Contraceptives Drugs Sales Quantity by Region (2019-2024) & (K Unit)
Table 106. Asia-Pacific Contraceptives Drugs Sales Quantity by Region (2025-2030) & (K Unit)
Table 107. Asia-Pacific Contraceptives Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 108. Asia-Pacific Contraceptives Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 109. South America Contraceptives Drugs Sales Quantity by Type (2019-2024) & (K Unit)
Table 110. South America Contraceptives Drugs Sales Quantity by Type (2025-2030) & (K Unit)
Table 111. South America Contraceptives Drugs Sales Quantity by Application (2019-2024) & (K Unit)
Table 112. South America Contraceptives Drugs Sales Quantity by Application (2025-2030) & (K Unit)
Table 113. South America Contraceptives Drugs Sales Quantity by Country (2019-2024) & (K Unit)
Table 114. South America Contraceptives Drugs Sales Quantity by Country (2025-2030) & (K Unit)
Table 115. South America Contraceptives Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 116. South America Contraceptives Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 117. Middle East & Africa Contraceptives Drugs Sales Quantity by Type (2019-2024) & (K Unit)
Table 118. Middle East & Africa Contraceptives Drugs Sales Quantity by Type (2025-2030) & (K Unit)
Table 119. Middle East & Africa Contraceptives Drugs Sales Quantity by Application (2019-2024) & (K Unit)
Table 120. Middle East & Africa Contraceptives Drugs Sales Quantity by Application (2025-2030) & (K Unit)
Table 121. Middle East & Africa Contraceptives Drugs Sales Quantity by Region (2019-2024) & (K Unit)
Table 122. Middle East & Africa Contraceptives Drugs Sales Quantity by Region (2025-2030) & (K Unit)
Table 123. Middle East & Africa Contraceptives Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 124. Middle East & Africa Contraceptives Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 125. Contraceptives Drugs Raw Material
Table 126. Key Manufacturers of Contraceptives Drugs Raw Materials
Table 127. Contraceptives Drugs Typical Distributors
Table 128. Contraceptives Drugs Typical Customers
List of Figures
Figure 1. Contraceptives Drugs Picture
Figure 2. Global Contraceptives Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Contraceptives Drugs Consumption Value Market Share by Type in 2023
Figure 4. Long-acting Contraceptives Examples
Figure 5. Short-acting Contraceptives Examples
Figure 6. Emergency Contraceptives Examples
Figure 7. Global Contraceptives Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Contraceptives Drugs Consumption Value Market Share by Application in 2023
Figure 9. Hospital Examples
Figure 10. Pharmacy Examples
Figure 11. Other Examples
Figure 12. Global Contraceptives Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Contraceptives Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Contraceptives Drugs Sales Quantity (2019-2030) & (K Unit)
Figure 15. Global Contraceptives Drugs Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Contraceptives Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Contraceptives Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Contraceptives Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Contraceptives Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Contraceptives Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Contraceptives Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Contraceptives Drugs Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Contraceptives Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Contraceptives Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Contraceptives Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Contraceptives Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Contraceptives Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Contraceptives Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Contraceptives Drugs Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Contraceptives Drugs Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Contraceptives Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Contraceptives Drugs Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Contraceptives Drugs Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Contraceptives Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Contraceptives Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Contraceptives Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Contraceptives Drugs Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Contraceptives Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Contraceptives Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Contraceptives Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Contraceptives Drugs Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Contraceptives Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Contraceptives Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Contraceptives Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Contraceptives Drugs Consumption Value Market Share by Region (2019-2030)
Figure 54. China Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Contraceptives Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Contraceptives Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Contraceptives Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Contraceptives Drugs Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Contraceptives Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Contraceptives Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Contraceptives Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Contraceptives Drugs Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Contraceptives Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Contraceptives Drugs Market Drivers
Figure 75. Contraceptives Drugs Market Restraints
Figure 76. Contraceptives Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Contraceptives Drugs in 2023
Figure 79. Manufacturing Process Analysis of Contraceptives Drugs
Figure 80. Contraceptives Drugs Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Bayer Pfizer Teva Pharmaceutical Merck Actavis Johnson & Johnson Gedeon Richter Novo Nordisk A/S ZiZhu Baijingyu Huazhong
Related Reports
12 Feb 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
